‘Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62’: author's response
Outside this study, the laboratory of Daechan Park received research funding from GC Biopharma, unrelated to the present study in the manuscript. Also, the laboratory of H.M.K. received research funding from SK Bioscience, GC Biopharma, and Merck, all of which are unrelated to the present study in the manuscript. This research was partially supported by the National Research Foundation of Korea grant funded by the Ministry of Education (No. RS-2023-00285390).This research was partially supported by the National Research Foundation of Korea grant funded by the Ministry of Education (No. RS-2023-00285390)
